Skip to main content

Table 1 Baseline clinical characteristics of 33 patients with liver cirrhosis

From: Myocardial structural and functional changes in patients with liver cirrhosis awaiting liver transplantation: a comprehensive cardiovascular magnetic resonance and echocardiographic study

 AllChild-Pugh class A/BChild-Pugh class CP value
N = 33N = 10N = 23
Age (years)56.3 ± 9.958.8 ± 7.355.3 ± 10.80.355
Male (n, %)25 (75.8%)9 (90.0%)16 (69.6%)0.208
Systolic blood pressure (mmHg)113.47 ± 14.0111.5 ± 7.6114.4 ± 16.20.601
Diastolic blood pressure (mmHg)66.3 ± 12.360.9 ± 9.068.8 ± 12.90.094
Heart rate (/min)73.6 ± 15.763.3 ± 9.178.0 ± 16.00.002
Cirrhosis etiology (n, %)   0.296
 Viral20 (60.6%)8 (80.0%)12 (52.2%) 
  HBV17 (51.5%)6 (60.0%)11 (47.8%) 
  HCV3 (9.1%)2 (20.0%)1 (4.3%) 
 Alcoholic9 (27.3%)1 (10.0%)8 (34.8%) 
 Autoimmune hepatitis2 (6.1%)0 (0%)2 (8.7%) 
 Cryptogenic2 (6.1%)1 (10.0%)1 (4.3%) 
 Child-Pugh score9.8 ± 2.46.8 ± 1.311.1 ± 1.2< 0.001
 MELD score18.8 ± 7.411.1 ± 2.122.1 ± 6.3< 0.001
Underlying diseases (n, %)
 Hypertension8 (24.2%)4 (40.0%)4 (17.4%)0.164
 Diabetes mellitus9 (27.3%)4 (40.0%)5 (21.7%)0.279
Medication (n, %)
 Beta-blockers8 (24.2%)6 (60.0%)2 (8.7%)0.002
 Diuretics17 (51.5%)4 (40.0%)13 (56.5%)0.383
 ACEI/ARB3 (9.1%)2 (20%)1 (4.3%)0.151
Laboratory examination
 Hemoglobin (g/dL)10.6 ± 1.611.4 ± 1.610.2 ± 1.50.050
 Creatinine (mg/dL)0.9 ± 0.40.8 ± 0.20.9 ± 0.40.565
 Bilirubin (mg/dL)7.5 ± 8.51.7 ± 0.610.0 ± 9.1< 0.001
 Albumin (g/dL)2.9 ± 0.43.2 ± 0.42.7 ± 0.40.002
 PT (INR)1.9 ± 1.01.3 ± 0.22.1 ± 1.10.001
  1. Values are shown as number (%) or mean ± standard deviation
  2. HBV hepatitis B virus, HCV hepatitis C virus, MELD the model for end stage liver disease, ACEI angiotensin-converting enzyme inhibitors, ARB angiotensin II receptor blockers, PT prothrombin time, INR international normalized ratio